Drug Type Small molecule drug |
Synonyms 1α,25-dihydroxy-2β-(3-hydroxypropoxy)cholecalciferol, Eldecalcitol (JAN/INN), CT-081 + [4] |
Target |
Mechanism VDR agonists(Vitamin D receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date JP (21 Jan 2011), |
Regulation- |
Molecular FormulaC30H50O5 |
InChIKeyFZEXGDDBXLBRTD-AYIMTCTASA-N |
CAS Registry104121-92-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D07578 | Eldecalcitol |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Osteoporosis | JP | 21 Jan 2011 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Primary osteoporosis | Phase 3 | CN | 31 Aug 2015 |
Not Applicable | - | - | txiblptuqb(zhsyeerhsp) = govciacejx xvnvrtsmpx (flgsvspony ) | Positive | 01 May 2014 | ||
txiblptuqb(zhsyeerhsp) = igzmtmlimg xvnvrtsmpx (flgsvspony ) | |||||||
Phase 3 | 1,054 | xfsijhaolc(rnjntkqcaw) = zezmurtkpr vvmgaagmlq (stirucgnfw, 0.56 - 0.97) | Positive | 01 Oct 2011 | |||
xfsijhaolc(rnjntkqcaw) = dkhzjffzsb vvmgaagmlq (stirucgnfw ) | |||||||
Not Applicable | - | vnudopfpzf(olxxuyclrz) = onrwmhfjjv cafctxasll (skktsldynx ) | - | 16 Nov 2010 | |||
vnudopfpzf(olxxuyclrz) = yrhvrcqqoo cafctxasll (skktsldynx ) |